Insider · CIK 0001534002

Russell Angus C.

CIK 0001534002 Name as filed on the most recent filing

Filed as Russell Angus C. (10)

12 transaction lines · from 10 filings · filed 2013-06-18 to 2021-12-15 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

12 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-12-13 P, Open-market purchase Revance Therapeutics, Inc.RVNC 100,741, acquired Open Form 4 filing 0001479290-21-000173
2021-06-29 S, Open-market sale Lineage Cell Therapeutics, Inc.LCTX 14,018, disposed Open Form 4 filing 0001493152-21-015786
2020-11-12 S, Open-market sale Mallinckrodt plcMNKKQ 6,665, disposed Open Form 4 filing 0000950138-20-000467
2019-08-23 P, Open-market purchase TherapeuticsMD, Inc.TXMD 27,700, acquired Open Form 4 filing 0001387131-19-006399
2019-08-15 P, Open-market purchase TherapeuticsMD, Inc.TXMD 29,900, acquired Open Form 4 filing 0001387131-19-006191
2019-08-14 P, Open-market purchase TherapeuticsMD, Inc.TXMD 69,000, acquired Open Form 4 filing 0001387131-19-006191
2015-11-06 P, Open-market purchase Biotime IncBTX 191,500, acquired Open Form 4 filing 0001209191-15-079470
2015-08-25 P, Open-market purchase TherapeuticsMD, Inc.TXMD 80,784, acquired Open Form 4 filing 0001387131-15-002666
2015-05-12 P, Open-market purchase TherapeuticsMD, Inc.TXMD 215,317, acquired Open Form 4 filing 0001387131-15-001641
2013-08-27 P, Open-market purchase Intermune IncITMN 71,130, acquired Open Form 4 filing 0001209191-13-042231
2013-08-26 P, Open-market purchase Intermune IncITMN 24,743, acquired Open Form 4 filing 0001209191-13-042231
2013-06-14 P, Open-market purchase Questcor Pharmaceuticals IncQCOR 149,986, acquired Open Form 4 filing 0001181431-13-035608

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Russell Angus C., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001534002

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.